Focus on lifestyle change and the metabolic syndrome

Endocrinology and Metabolism Clinics of North America

Volumn 33, Issue 3, 2004, Pages 493-508

  Stone, Neil J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

BODY MASS; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; HUMAN; HYPOTENSION; INSULIN RESISTANCE; LIFESTYLE; LOW FAT DIET; METABOLIC SYNDROME X; PRIORITY JOURNAL; REVIEW; UNITED STATES; WEIGHT REDUCTION;

HUMANS; METABOLIC SYNDROME X; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 3242730110     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2004.03.009     Document Type: Review

References (52)

1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 106:(25):2002;3143-3421
2. Manson J.E., Willett W.C., Stampfer M.J., Colditz G.A., Hunter D.J., Hankinson S.E., et al. Body weight and mortality among women. N Engl J Med. 333:(11):1995;677-685
3. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 287:2002;356-359
4. Janssen I., Katzmarzyk P.T., Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 162:(18):2002;2074-2079
5. McGill H.C. Jr., McMahan C.A., Herderick E.E., Zieske A.W., Malcom G.T., Tracy R.E., et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Obesity accelerates the pregression of coronary atherosclerosis in young men. Circulation. 105:(23):2002;2712-2718
6. Bravata D.M., Sanders L., Huang J., Krumholz H.M., Olkin I., Gardner C.D., et al. Efficacy and safety of low carbohydrate diets: a systematic review. JAMA. 289:2003;1837-1850
7. Samaha F.F., Iqbal N., Seshadri P., Chicano K.L., Daily D.A., McGrory J., et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 348:2003;2074-2081
8. Foster G.D., Wyatt H.R., Hill J.O., McGuckin B.G., Brill C., Mohammed B.S., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 348:2003;2082-2090
9. Bonow R.O., Eckel R.H. Diet, obesity, and cardiovascular risk. N Engl J Med. 348:2003;2057-2058
10. Brehm B.J., Seeley R.J., Daniels S.R., D'Alessio D.A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 88:(4):2003;1617-1623
11. Ornish D.B.S., Scherwitz L.W., Billings J.H., Brown S.E., Gould K.L., Merritt T.A., et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 336:1990;129-133
12. Koertge J., Weidner G., Elliott-Eller M., Scherwitz L., Merritt-Worden T.A., Marlin R., et al. Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. Am J Cardiol. 91:2003;1316-1322
13. Watts G.F., Lewis B., Brunt J.N., Lewis E.S., Coltart D.J., Smith L.D., et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet. 339:(8793):1992;563-569
14. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 102:2000;2284-2299
15. Poppitt S.D., Keogh G.F., Prentice A.M., Williams D.E., Sonnemans H.M., Valk E.E., et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 75:2002;11-20
16. Wing R.R., Hill J.O. Successful weight loss maintenance. Annu Rev Nutr. 21:2001;323-341
17. Pan X., Li G., Hu Y., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 20:1997;537-544
18. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346:2002;393-403
19. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al., for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344:2001;1343-1350
20. Liao D., Asberry P.J., Shofer J.B., Callahan H., Matthys C., Boyko E.J., et al. Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance. Diabetes Care. 25:2002;1504-1510
21. Anderssen S.A., Hjermann I., Urdal P., Torjesen P.A., Holme I. Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the "atherothrombogenic syndrome." Oslo Diet and Exercise Study (ODES). A randomized trial. J Intern Med. 240:1996;203-209
22. Katzel L.I., Bleecker E.R., Colman E.G., Rogus E.M., Sorkin J.D., Goldberg A.P. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA. 274:(24):1995;1915-1921
23. Lamon-Fava S., Wilson P.W.F., Schaefer E.J. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 16:1996;1509-1515
24. Knopp R.H., Walden C.E., Retzlaff B.M., McCann B.S., Dowdy A.A., Albers J.J., et al. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study. JAMA. 279:(17):1998;1345-1346
25. Frost G., Leeds A.A., Dore C.J., Madeiros S., Brading S., Dornhorst A. Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet. 353:1999;1269-1276
26. Sacks F.M., Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 113:2002;13-24
27. Dreon D.M., Fernstrom H.A., Williams P.T., Krauss R.M. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. Am J Clin Nutr. 71:2000;1611-1616
28. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr. 67:(3 Suppl):1998;577S-582S
29. Katzmarzyk P.T., Leon A.S., Wilmore J.H., Skinner J.S., Rao D.C., Rankinen T., et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc. 35:2003;1703-1709
30. Institute of Medicine of the National Academies. Dietary reference intakes. 2002;National Academies Press, Washington, DC
31. Slentz C.A., Duscha B.D., Johnson J.L., Ketchum K., Aiken L.B., Samsa G.P., et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity. STRRIDE - a randomized controlled study. Arch Intern Med. 164:2004;31-39
32. Brown C.D., Higgins M., Donato K.A., Rohde F.C., Garrison R., Obarzanek E., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 8:2000;605-619
33. Wilson P.W.F., Kannel W.B., Silbershatz H., D'Agostino R.B. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 159:1999;1104-1109
34. Reisin E., Abel R., Modan M., Silverberg D.S., Eliahou H.E., Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 298:(1):1978;1-6
35. Cassano P.A., Segal M.R., Vokonas P.S., Weiss S.T. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol. 1:1990;33-48
36. Rocchini A.P., Katch V., Schork A., Kelch R.P. Insulin and blood pressure during weight loss in obese adolescents. Hypertension. 10:1987;267-273
37. Su H.Y., Sheu W.H., Chin H.M., Jeng C.Y., Chen Y.D., Reaven G.M. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens. 8:1995;1067-1071
38. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F. High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease. Hypertension. 36:2000;226-232
39. Zavaroni I., Mazza S., Dall'Aglio E., Gasparini P., Passeri M., Reaven G.M. Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med. 231:1992;235-240
40. Appel L.J., Moore F.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 336:1997;1117-1124
41. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 344:2001;3-10
42. Juhan-Vague I., Pyke S.D.M., Alessi M.C., Jespersen J., Haverkate F., Thompson S.G. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 94:1996;2057-2063
43. Mavri A., Stegnar M., Krebs M., Sentocnik J.T., Geiger M., Binder B.R. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. Arterioscler Thromb Vasc Biol. 19:(6):1999;1582-1587
44. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events an 8-year follow-up of 14,719 initially healthy American women. Circulation. 107:2003;391-397
45. Wannamethee S.G., Lowe G.D., Whincup P.H., Whincup P.H., Rumley A., Walker M., et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 105:2002;1785-1790
46. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Rimm E.B. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 11:2003;1055-1064
47. Tomaszewski M., Charchar F.J., Przybycin M., Crawford L., Wallace A.M., Gosek K., et al. Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go. Arterioscler Thromb Vasc Biol. 23:(9):2003;1640-1644
48. Lee K.W., Lip G.Y. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 163:(19):2003;2368- 2392
49. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. 1998;National Heart, Lung and Blood Institute, Bethesda, MD. NIH Publication #98-4083
50. US Department of Health and Human Services. Physical activity and health: a report of the Surgeon General. 1996;US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA
51. Manson J.E., Skerrit P.J., Greenland P., VanItallie T. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med. 164:2004;249-258
52. Cook S., Weitzman M., Auinger P., Nguyen M., Dietz W.H. Prevalence of a metabolic syndrome phenotype in adolescents. Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 157:2003;821-827